Healthcare Hedge Fund Just Invested $24.5M in Immunovant
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
This article explains When To Use Total Return Index Rather Than Price Index, outlining scenarios where total return offers clearer insight.
28,063 articlesA healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
The weight loss drug space has become a focus for growth-minded investors. This guide weighs Eli Lilly's proven progr...
Is $900,000 enough outlast rmds? A closer look at 2026 retirement math shows a first-year withdrawal around $34,000 o...
A rising tax trap could convert a $260,000 401(k) deferral into a looming $700K RMD burden. The piece explains the ma...
A fresh take on dine brands (din) 2025, focusing on Q4 signals, brand momentum, and how investors can position themse...
As memory cycles swing, the safest play in July may not be the pure-play chips you expect. This article explains why ...
As the S&P 500 faltered in early 2026, the Simplify Managed Futures Strategy ETF (CTA) posted gains, highlighting a h...
A defensive utility ETF is gaining attention as AI infrastructure ramps up, potentially making this “boring” ETF one ...
Nvidia is facing a mixed start to 2026, but the long-term case remains intact. This article explains why a 40% jump b...
When work gets intense, money decisions get louder. This article breaks down how intensity at work affects your budge...
The latest Case-Shiller release shows america’s housing market decline broadening from the Sun Belt to major coastal ...
Ford famously pulled back from most sedans years ago. This article examines the strategic pivot, what a sedan comebac...